Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

BackgroundEGFR-positive Non-small Cell Lung Cancer (NSCLC) is a dynamic entity and tumor progression and resistance to tyrosine kinase inhibitors (TKIs) arise from the accumulation, over time and across different disease sites, of subclonal genetic mutations. For instance, the occurrence of EGFR T79...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Federico Cucchiara, Marzia Del Re, Simona Valleggi, Chiara Romei, Iacopo Petrini, Maurizio Lucchesi, Stefania Crucitta, Eleonora Rofi, Annalisa De Liperi, Antonio Chella, Antonio Russo, Romano Danesi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-12-01
coleção:	Frontiers in Oncology
Assuntos:	non-small cell lung cancer EGFR liquid biopsy cell free DNA radiomics tyrosine kinase inhibitors
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2020.593831/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!